Biomarkers for depression: recent insights, current challenges and future prospects
Rebecca Strawbridge,1 Allan H Young,1,2 Anthony J Cleare1,2 1Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, 2South London and Maudsley NHS Foundation Trust, London, UK Abstract: A plethora...
Saved in:
Main Authors: | Strawbridge R, Young AH, Cleare AJ |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/f59815e2d52047cea9e4c56191c869f2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of Ketamine in the Treatment of Patients with Major Depressive Disorder
by: F Kheirkhah, et al.
Published: (2010) -
Management of Treatment-Resistant Depression: Challenges and Strategies
by: Voineskos D, et al.
Published: (2020) -
MicroRNAs as Critical Biomarkers of Major Depressive Disorder: A Comprehensive Perspective
by: Miguel A. Ortega, et al.
Published: (2021) -
El diagnóstico diferencial entre la Depresión Bipolar y la Depresión Monopolar en la práctica clínica
by: LEYTON A,FANNY, et al.
Published: (2010) -
Nuevas perspectivas en la biología de la depresión
by: Silva,Hernán
Published: (2002)